You are here:
Home / Archives for ALKS
“It’s déjà vu all over again” – Yogi Berra
With Opening Day less than a month away, it seems only fitting to reference one of the most quoted personalities of our time to describe our analysis of the biotechnology sector in 2010. In this article, we review our favorable outlook for the industry, draw comparisons with [...]
Filed under Articles · Tagged with Adventrix Pharmaceuticals, Alfrezza, Alkermes, ALKS, AMAG, AMAG Pharmaceuticals, AMLN, Amylin, ANX, Astellas Pharma, biotechnology, Cell Therapeutics, CEPH, Cephalon, Ception, CTIC, DCTH, DelCath Systems, Dendreon, DNDN, FDA approvals, InterMune, ISIS, Isis Pharmaceuticals, ITMN, Life Sciences Industry Outlook, MannKind Corporation, MDVN, Medivation, MNKD, NASDAQ Biotech Index, Novelos, NVLT, OSI Pharmaceuticals, OSIP, Provenge, Xenoport, XNPT
Although a controversial topic, activist hedge funds and private equity firms typically use a small equity stake in an underperforming company to put public pressure on its management and board of directors with the goal of increasing stakeholder value through cost cutting, changes in corporate strategy or management, capital restructuring, asset divestiture and other tactics. [...]
Filed under Articles · Tagged with Abelcet, activism, activist, Adagen, Alexander Denner, Alkermes, ALKS, AMLN, Amylin Pharmaceuticals, AstraZeneca plc, Avonex, AZN, BIIB, Biogen Idec, biotech, biotechnology, Biotechnology Value Fund, BMY, Bristol-Myers Squibb, Byetta, canfosfamide, Carl Icahn, cetuximab, DellaCamera Capital Management, DepoCyt, Eastbourne Capital Management, Eli Lilly, Eli Lilly & Co, EMIS, Emisphere Technologies, Endo Pharmaceuticals, ENDP, ENZN, Enzon Pharmaceuticals, Erbitux, EXEL, Exelixis, exenatide, Icahn Management, ImClone, interferon beta-1a, interferon beta-1b, LLY, Medarex, MedImmune, medx, multiple sclerosis, NASDAQ Biotechnology Index, NBI, Novartis AG, NVS, Oncaspar, Regeneron Pharmaceuticals, REGN, Richard Mulligan, shareholder activist, Telcyta, Telik, TELK, Third Point LLC
